metoclopramide has been researched along with Cystic Fibrosis in 3 studies
Metoclopramide: A dopamine D2 antagonist that is used as an antiemetic.
metoclopramide : A member of the class of benzamides resulting from the formal condensation of 4-amino-5-chloro-2-methoxybenzoic acid with the primary amino group of N,N-diethylethane-1,2-diamine.
Cystic Fibrosis: An autosomal recessive genetic disease of the EXOCRINE GLANDS. It is caused by mutations in the gene encoding the CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR expressed in several organs including the LUNG, the PANCREAS, the BILIARY SYSTEM, and the SWEAT GLANDS. Cystic fibrosis is characterized by epithelial secretory dysfunction associated with ductal obstruction resulting in AIRWAY OBSTRUCTION; chronic RESPIRATORY INFECTIONS; PANCREATIC INSUFFICIENCY; maldigestion; salt depletion; and HEAT PROSTRATION.
| Excerpt | Relevance | Reference |
|---|---|---|
| "When cisapride was given, there was frequent irregular contractile activity, faster gastric emptying, and no symptoms of lethargy." | 5.27 | Absent postprandial duodenal motility in a child with cystic fibrosis. Correction of the symptoms and manometric abnormality with cisapride. ( Hyman, PE, 1986) |
| " To assess the hypothalamic-pituitary system we performed the metoclopramide test (by Cerucal) on 30 children suffering from CF (n = 10), bronchial asthma (n = 10) or pyelonephritis (n = 10) for PROL, LH, FSH, TSH and HGH." | 3.68 | Serum prolactin concentration and hypothalamic-pituitary hormone release in CF-children. ( Abel, E; Abel, J; Ballke, EH; Bruns, R; Griefahn, B; Heydolph, F; Weber, A; Wiersbitzky, H; Wiersbitzky, S, 1991) |
| "When cisapride was given, there was frequent irregular contractile activity, faster gastric emptying, and no symptoms of lethargy." | 1.27 | Absent postprandial duodenal motility in a child with cystic fibrosis. Correction of the symptoms and manometric abnormality with cisapride. ( Hyman, PE, 1986) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Edwards, L | 1 |
| Wiersbitzky, S | 1 |
| Ballke, EH | 1 |
| Abel, E | 1 |
| Weber, A | 1 |
| Abel, J | 1 |
| Heydolph, F | 1 |
| Wiersbitzky, H | 1 |
| Bruns, R | 1 |
| Griefahn, B | 1 |
| Hyman, PE | 1 |
3 other studies available for metoclopramide and Cystic Fibrosis
| Article | Year |
|---|---|
Hyperprolactinaemia in a patient with cystic fibrosis.
Topics: Acetaminophen; Analgesics, Non-Narcotic; Antiemetics; Cystic Fibrosis; Domperidone; Drug Combination | 2007 |
Serum prolactin concentration and hypothalamic-pituitary hormone release in CF-children.
Topics: Adolescent; Adult; Asthma; Child; Child, Preschool; Cystic Fibrosis; Female; Humans; Male; Metoclopr | 1991 |
Absent postprandial duodenal motility in a child with cystic fibrosis. Correction of the symptoms and manometric abnormality with cisapride.
Topics: Bethanechol; Bethanechol Compounds; Cisapride; Cystic Fibrosis; Duodenal Obstruction; Duodenum; Esop | 1986 |